世界の癌/腫瘍プロファイリング市場...市場調査レポートについてご紹介

【英文タイトル】Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table Of Content

1 Introduction (Slide No. – 20)
1.1 Key Take-Aways
1.2 Logical Assumptions For This Study Based On Reliable Sources
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Secondary & Primary Resources

2 Executive Summary (Slide No. – 27)

3 Tumor Profiling Technology Landscape (Slide No. – 31)
3.1 Technology Overview
3.2 Milestones In Cancer Research
3.3 Tumor Profiling Segments
3.3.1 Genomics
3.3.2 Proteomics
3.3.3 Metabolomics
3.3.4 Epigenetics
3.3.4.1 Epigenetic Genes Disturbed In Cancer Conditions
3.3.4.2 Cancers And Associated Epigenetic Disruptions
3.4 The Biological Organization Of The “-Omes”
3.5 Tumor Profiling Technologies
3.5.1 Next-Generation Sequencing (NGS)
3.5.2 Fluorescence/Chromogenic In Situ Hybridization (Fish/Cish)
3.5.3 Immunohistochemistry (IHC)
3.5.4 Microarray
3.5.5 Quantitative Pcr (QPCR)
3.6 Key Tumor Profiling Technological Innovations
3.7 Key Tumor Profiling Products & Services In The Market

4 Tumor Profiling Research Portfolio (Slide No. – 51)
4.1 Tumor Profiling Research Network

5 Value Chain Analysis (Slide No. – 54)
5.1 Overview
5.2 Key Stakeholders
5.3 Gap Analysis
5.4 Porter’s Five Forces Analysis

6 Market Landscape Analysis (Slide No. – 63)
6.1 “Tumor Profiling Technologies: Market Segmentation”
6.2 “Tumor Profiling Technologies: Global Impact
6.3 Market Forecast: Overview, 2013-2018
6.4 “Global Cancer Profiling: Market Revenue Forecast, 2013-2018″
6.4.1 “Global Cancer Profiling: Market Revenue, By Geography”
6.4.2 Global Cancer Profiling Market Share, By Geography
6.4.3 Global Cancer Profiling: Market Revenue, By Segment
6.4.3.1 Global Cancer Profiling: Market Share, By Segment
6.4.3.2 Genomics Market, By Region
6.4.3.3 Proteomics Market, By Region
6.4.3.4 Metabolomics Market, By Region
6.4.3.5 Epigenetics Market, By Region
6.4.4 Global Cancer Profiling Market Revenue, By Technology
6.4.4.1 Global Cancer Profiling Market Share, By Technology
6.4.4.2 Next-Generation Sequencing Market, By Region
6.4.4.3 Fluorescence/Chromogenic In Situ Hybridization Market, By Region
6.4.4.4 Immunohistochemistry Market, By Region
6.4.4.5 Quantitative Pcr Market, By Region
6.4.4.6 Microarray Market, By Region
6.4.5 Global Cancer Profiling Market Revenue, By Application
6.4.5.1 Global Cancer Profiling Market Share, By Application
6.4.5.2 Personalized Medicine Market, By Region
6.4.5.3 Biomarker Discovery Market, By Region
6.4.5.4 Diagnostics Market, By Region
6.4.5.5 Prognosis Market, By Region
6.4.5.6 Research Applications Market, By Region
6.5 Market Dynamics
6.5.1 Drivers
6.5.1.1 Tumor Profiling-Impact Analysis Of Drivers
6.5.2 Restraints
6.5.2.1 Tumor Profiling-Impact Analysis Of Restraints

7 Technology Adoption And Development Potential, By Geography (Slide No. – 114)
7.1 Geographic Adoption And Development Potential-Overview
7.2 North America
7.3 Europe
7.4 Asia
7.5 Rest Of The World (ROW)

8 Technology Investment Analysis (Slide No. – 122)
8.1 Investment Climate Assessment
8.2 Investor Network
8.3 Funds And Investments On Tumor/Cancer Profiling
8.4 Funds And Investments From Nih-By Fiscal Year
8.5 Funds And Investments From Nih-By Its Associated Institutes/Centers (2008 – 2013)
8.6 Top 10 Organizations To Receive Highest Funding From Nih During 2008-2013
8.7 Funds From The American Cancer Society As Of September 01, 2013 For Various Cancer Types
8.8 Insights On Current And Future Technology Investment Trends

9 Competitive Landscape Analysis (Slide No. – 136)
9.1 Competitive Landscape Analysis
9.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2010-2013)
9.3 Technologies Available For Licensing & Acquisition For Stakeholders

10 Patent Analysis (Slide No. – 141)
10.1 Overview
10.2 Ip Strength Analysis-By Cancer Segments

11 Analyst Insights And Recommendations (Slide No. – 144)
11.1 Key Insights On The Market
11.2 Strategic Recommendations
11.3 Open Opportunity Invitations In The Field For Business Development

12 Company Profiles (Slide No. – 148)
12.1 Boreal Genomics, Inc.
12.2 Caris Life Sciences
12.3 Genomic Health, Inc.
12.4 Illumina, Inc.
12.5 Life Technologies Corporation
12.6 Neogenomics Laboratories
12.7 Oxford Gene Technology Ltd
12.8 Precision Therapeutics, Inc.
12.9 Biotheranostics
12.10 Proteome Sciences Plc
12.11 Agendia Nv
12.12 Nanostring Technologies
12.13 Rational Therapeutics
12.14 Oncopath Laboratory
12.15 Ribomed Biotechnologies


【レポート販売概要】

■ タイトル:世界の癌/腫瘍プロファイリング市場
■ 英文:Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
■ 発行日:2013年9月
■ 調査会社:MarketsandMarkets
■ 商品コード:BT 2123
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。